Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 10
Submit an article Journal homepage
1,003
Views
21
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Report of the 6th International Workshop on PET in lymphoma

Cristina NanniNuclear Medicine and Hematology, University of Bologna, Bologna, Italy;
,
Anne Ségolène CottereauNuclear Medicine, Hôpital Tenon, Paris, France;
,
Egesta LopciNuclear Medicine, Instituto Clinica Humanitas, IRCCS, Milano, Italy;
,
Caroline Bodet-MilinNuclear Medicine and Haematology, CHU Nantes, Nantes, France;
,
Monica CoronadoNuclear Medicine, La Paz University Hospital, Madrid, Spain;
,
Barbara ProHematology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA;
,
Wong Seog KimHematology, Samsung Medical Center, Seoul, Korea;
,
Judith TrotmanHematology, Concord Hospital, University of Sydney, Sydney, Australia;
,
Sally BarringtonPET Center, Guy’s and St Thomas’ Hospital, King’s College, London, UK;
,
Ulrich DuhrsenHematology, Universitätsklinikum, Essen, Germany;
,
Thierry Vander BorghtNuclear Medicine and Haematology, Université catholique de Louvain, CHU UCL Namur, Namur, Belgium;
,
Elena ZamagniNuclear Medicine and Hematology, University of Bologna, Bologna, Italy;
,
Françoise Kraeber-BodéréNuclear Medicine and Haematology, CHU Nantes, Nantes, France;
,
Christina MessiouThe Royal Marsden Hospital, London, UK;
,
Alain RahmouniRadiology, Lysa Imaging and Haematology, Hôpitaux Universitaires Henri Mondor, Créteil, France;
,
Irène BuvatUnité d’Imagerie Moléculaire in Vivo, Orsay, France;
,
Marc AndreNuclear Medicine and Haematology, Université catholique de Louvain, CHU UCL Namur, Namur, Belgium;
,
Mark HertzbergHaematology, Prince of Wales Hospital and Community Health Services, Sydney, Australia;
,
Wim OyenThe Royal Marsden Hospital, London, UK;
,
Olivier CasasnovasHaematology, CHU Dijon, Dijon, France;
,
Stefano LuminariNuclear Medicine and Haematology, Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia, Italy;
,
Laurent GarderetHaematology, Hôpital Saint Antoine, Paris, France;
,
Françoise MontraversNuclear Medicine, Hôpital Tenon, Paris, France;
,
Carsten KobeNuclear Medicine, University Hospital of Cologne, Cologne, Germany;
,
Regine KlugeNuclear Medicine, University Hospital, Leipzig, Germany;
,
Annibale VersariNuclear Medicine and Haematology, Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia, Italy;
,
Emanuele ZuccaHaematology, Istituto Oncologico della Swizzera Italiana, Bellizona, Switzerland;
,
Philippe MoreauNuclear Medicine and Haematology, CHU Nantes, Nantes, France;
,
Bruce ChesonHaematology, Lombardi Comprehensive Cancer Center, Washington, DC, USA;
,
Corinne HaiounRadiology, Lysa Imaging and Haematology, Hôpitaux Universitaires Henri Mondor, Créteil, France;
,
Andrea GallaminiResearch, Innovation and Statistics Department, A. Lacassagne Cancer Center, Nice, France
&
Michel MeignanRadiology, Lysa Imaging and Haematology, Hôpitaux Universitaires Henri Mondor, Créteil, France; Correspondence[email protected]
 show all
Pages 2298-2303 | Received 25 Dec 2016, Accepted 15 Feb 2017, Published online: 07 Mar 2017
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

Two hundred and ten nuclear medicine physicians, radiologists, and hematologists from 26 countries attended the 6th International Workshop on Positron Emission Tomography (PET) in Lymphoma and Myeloma held in Menton, France, in September 2016. The meeting was under the auspices of the European Lymphoma Institute (ELI), the European Association of Nuclear Medicine (EANM) the Lymphoma Study Association (LYSA), the Italian Foundation on Lymphoma (FIL) and the Carnot Institute for Lymphoma (CALYM). Forty scientific posters were presented. For the first time, specialists in the field of multiple myeloma (MM) were involved in the expert session. The aim was to establish from the experience of Italian and French studies new guidelines of FDG-PET/CT reporting for myeloma staging and restaging. The meeting dedicated an entire session to MM imaging followed by a session on the role of PET in Peripheral T cell Lymphoma. An entire session addressed the issues of Deauville scale particularly for end treatment assessment and the challenging consequences of immunomodulatory treatments on PET reporting. A specific session presented the potential role of baseline metabolic tumor measurement to predict outcome and identify different risk categories and the main results obtained in different lymphoma entities were described. Whether it could replace clinical staging has been extensively discussed. The more recent results obtained in the H10 trial have been presented and compared to the published data in early stage Hodgkin lymphoma. Finally, the ongoing studies using PET for guiding therapeutic strategies have been reported by the various lymphoma cooperative groups that participated to the meeting.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2017.1298752

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.